Quarterly report [Sections 13 or 15(d)]

Note 2 - Significant Accounting Policies (Tables)

v3.25.1
Note 2 - Significant Accounting Policies (Tables)
3 Months Ended
Mar. 31, 2025
Notes Tables  
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]
   

As of

 
   

March 31,

 
   

2025

   

2024

 

Unvested restricted stock units/awards

    744       1,028  

Deferred stock units

    235,000        

Warrants

    1,476,200       745,139  

Options

    256,474       22,474  

Class A Preferred shares(1)

    223       223  

Total potential dilutive effect

    1,968,641       768,864